Targeting Insomnia to Enhance Hot Flush Treatment in Women Receiving Therapy for Breast Cancer or Breast Cancer Risk-Reduction.

Trial Profile

Targeting Insomnia to Enhance Hot Flush Treatment in Women Receiving Therapy for Breast Cancer or Breast Cancer Risk-Reduction.

Completed
Phase of Trial: Phase II

Latest Information Update: 01 Sep 2010

At a glance

  • Drugs Venlafaxine (Primary) ; Zolpidem (Primary) ; Serotonin uptake inhibitors
  • Indications Hot flashes; Sleep disorders
  • Focus Therapeutic Use
  • Most Recent Events

    • 04 May 2010 Actual end date (Mar 2010) added as reported by ClinicalTrials.gov.
    • 04 May 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 04 Dec 2008 Status changed from recruiting to active, no longer recruiting, based on information from ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top